Conditions and perspectives in the German health insurances system
Special Report by the Monopolies Commission pursuant to Section 44(1)(4) ARC, 7 March 2017
- The Monopolies Commission criticizes competition deficits in statutory and private health insurance, which reduce the efficiency of the health insurance system and burden the insureds with unnecessary cost.
- The Monopolies Commission argues for more leeway for the health care management in statutory health insurance and advocates developing the risk adjustment scheme (Risikostrukturausgleich) further to eliminate distortions of competition.
- The Monopolies Commission proposes a concept for rendering the change of private health insurance providers more attractive and recommends to facilitate the combination of tariffs whenever private insurers merge.
XXIst Main Report: Competition 2016
Biennial Report of the Monopolies Commission under § 44(1) ARC, 20 September 2016
The Monopolies Commission has submitted its twenty-first Biennial Report ('Hauptgutachten') pursuant to § 44(1) of the Act Against Restraints on Competition (ARC) to the Federal Minister of the Economy and Energy. The Report is entitled:
"XXIst Main Report – Competition 2016".
The subject matters of the Report encompass the following:
- The analysis of company concentration and the competition authorities' decision practice, as provided by law;
- The following additional subjects: the ministerial proposal for a 9th amendment to the German ARC, the regulation of airports, the central marketing of football broadcasting rights, and digital markets: the sharing economy and FinTechs.
Prof. Dr. Jürgen Kühling, LL.M. appointed as new member of the Monopolies Commission, Dagmar Kollmann and Dr. Angelika Westerwelle appointed for another term
Press Release, Bonn, 14 July 2016
The Federal President has appointed Prof. Dr. Jürgen Kühling, LL.M. as member of the Monopolies Commission for a term from 1 July 2016 to 30 June 2020. Dagmar Kollmann and Dr. Angelika Westerwelle, both entrepreneurs and supervisory board members, were appointed for another term. Dagmar Kollmann has been a Member of the Monopolies Commission since 1 January 2012, and Dr. Angelika Westerwelle since 1 July 2008.
